Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma
NCT02300506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 507
Last updated 2018-11-05
Summary
The objective of this study is to determine the survival status of patients enrolled in study GLI01S (all-case observational study).
Conditions
- Malignant Glioma
Interventions
- OTHER
-
No intervention
Sponsors & Collaborators
-
Eisai Co., Ltd.
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-10
- Primary Completion
- 2016-07-10
- Completion
- 2016-07-10
Countries
- Japan
Study Locations
More Related Trials
-
Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas
NCT04216537 ·Status: UNKNOWN
-
A Multicenter, Prospective Study for Glioblastoma Patients
NCT07162324 ·Status: NOT_YET_RECRUITING
-
Comparative Study of Intraoperative MRI-guided vs. Conventional Glioma Surgery
NCT01394692 ·Status: COMPLETED ·Phase: NA
-
11C-Methionine PET as Prognostic Marker of Gliomas
NCT02518061 ·Status: COMPLETED
-
Image Guided Therapy in the Treatment of Gliomas
NCT01263821 ·Status: TERMINATED ·Phase: NA
-
Quality of Life and Patient Needs in Advanced High Grade Gliomas
NCT05039346 ·Status: COMPLETED
-
Supratotal Resection for Gliomas Within Noneloquent Areas
NCT02676687 ·Status: UNKNOWN ·Phase: NA
-
Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes
NCT06116903 ·Status: RECRUITING ·Phase: NA
-
Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome
NCT04562077 ·Status: UNKNOWN
-
Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over
NCT02892708 ·Status: COMPLETED ·Phase: PHASE3
-
Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs
NCT06203496 ·Status: RECRUITING
-
Glioma Patients Registry Based on Radiological, Histopathological and Genetic Analysis
NCT04220424 ·Status: UNKNOWN
-
FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)
NCT06451042 ·Status: COMPLETED
-
Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy
NCT03534050 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence
NCT05735171 ·Status: COMPLETED ·Phase: NA
-
Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence
NCT04215224 ·Status: RECRUITING
-
68Ga-P16-093 PET/CT Imaging in Glioma Patients
NCT05569434 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Prospective Real-World Study of Pathology AI for Glioma Molecular Prediction
NCT07263711 ·Status: RECRUITING
-
A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases
NCT05564949 ·Status: RECRUITING ·Phase: NA
-
Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR Imaging
NCT03102203 ·Status: UNKNOWN
-
Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients
NCT05964153 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
NCT05331521 ·Status: RECRUITING ·Phase: PHASE3
-
Long Term Implications of Rare Brain Tumours'
NCT04708548 ·Status: COMPLETED
-
Prognostic Awareness and Patient-Physician Communication in Malignant Glioma
NCT02023346 ·Status: COMPLETED
-
Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma
NCT06885333 ·Status: COMPLETED